View |
2021-05-24-0237
|
INSULIN GLARGINE
|
GLARITUS
|
BRP-037
|
DV10195
|
Packaging lot (Box & Vial): DV10195
|
30 November 2022
|
25 May 2021
|
View |
2021-05-28-0250
|
FOLLITROPIN ALFA
|
GONAL-F
|
BR-829
|
BA070829
|
Packaging lot (Box & Pre-filled Pen): BA070829; (Needle): 20G21G8711
|
30 November 2022
|
31 May 2021
|
View |
2021-05-28-0251
|
FOLLITROPIN ALFA
|
GONAL-F
|
BR-831
|
BA070792
|
Packaging lot (Box & Pre-filled Pen): BA070792; (Needle): 20H19G8781
|
30 November 2022
|
31 May 2021
|
View |
2021-06-11-0268
|
MENOTROPHIN
|
MENOPUR
|
BR-992
|
S16167
|
Packaging Lot (Box & Vial): S16167H; (Diluent): S01027H
|
30 November 2022
|
14 June 2021
|
View |
2021-06-11-0269
|
EPOETIN ALFA
|
PRONIVEL
|
BRP-067
|
2255
|
Packaging Lot (Box & Pre-filled Syringe): 2255
|
30 November 2022
|
17 June 2021
|
View |
2021-06-23-0291
|
ATEZOLIZUMAB
|
TECENTRIQ
|
BR-1280
|
H0273
|
Packaging Lot (Box & Vial): 0370G142; (Diluent): 0700S4017 & 0700S4018
|
30 November 2022
|
24 June 2021
|
View |
2021-07-02-0311
|
EPOETIN BETA
|
RECORMON
|
BRP-084
|
H0716
|
Packaging Lot (Box): H0716H08
|
30 November 2022
|
8 July 2021
|
View |
2021-07-14-0341
|
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B, POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED) [DTap-IPV-HepB-Hib]
|
HEXAXIM
|
BR-919
|
U3B62
|
Packaging Lot (Box): U3B622V; (PFS): U3B62; (Needle 23G x 1"): 2006013; (Needle 25G x 5/8"): 2007032
|
30 November 2022
|
16 July 2021
|
View |
2021-07-28-0377
|
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)
|
TETRAXIM
|
BR-518
|
U3C49
|
Packaging Lot (Box): U3C493V; (Pre-filled Syringe): U3C49; (Needle (25G x 5/8"): 2007036; (Needle (23G x 1"): 2006034
|
30 November 2022
|
30 July 2021
|
View |
2021-07-28-0378
|
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B, POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED) [DTap-IPV-HepB-Hib]
|
HEXAXIM
|
BR-919
|
U3C48
|
Packaging Lot (Box): U3C482V; (Pre-filled Syringe): U3C48; (Needle (25G x 5/8"): 2007032; (Needle (23G x 1"): 2006034
|
30 November 2022
|
30 July 2021
|
View |
2021-09-29-0492
|
INACTIVATED POLIOMYELITIS VACCINE (TYPE 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-929
|
U3P95
|
Packaging Lot (Box): U3P951V; (Vial): U3P95
|
30 November 2023
|
30 September 2021
|
View |
2021-10-21-0503
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161W010
|
Packaging Lot (Box & Vial): 0161W010; (Diluent): 0681S1070
|
30 November 2023
|
25 October 2021
|
View |
2022-01-14-0008
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-885
|
0151N001
|
Packaging Lot (Box & Vial): 0151N001; (Diluent): 0679S1055
|
30 November 2023
|
18 January 2022
|
View |
2022-01-19-0014
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (rDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CD992
|
Packaging Lot (Box): A21CD992A; (Vial): A21FD992A; (Pre-filled Syringe): A21LD992A; (Needle 25G x 1"): 2012018
|
30 November 2023
|
21 January 2022
|
View |
2022-02-03-0025
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CE023
|
Packaging Lot (Box): A21CE021A; (PFS): A21LE023A; (Vial): A21LE023A
|
30 November 2023
|
8 February 2022
|
View |
2022-04-22-0098
|
TETANUS TOXOID (ADSORBED)
|
T-VAC
|
BR-326
|
2591Q007C
|
Packaging Lot (Box & Ampoule): 2591Q007C
|
30 November 2024
|
26 April 2022
|
View |
2022-07-18-0187
|
TETANUS TOXOID (ADSORBED)
|
T-VAC
|
BR-326
|
2591Q007B
|
Packaging Lot (Box & Ampoule): 2591Q007B
|
30 November 2024
|
21 July 2022
|
View |
2022-07-18-0188
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-567
|
0321Q018E
|
Packaging Lot (Box & Vial): 0321Q018E
|
30 November 2024
|
21 July 2022
|
View |
2023-01-06-0005
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03322003
|
Packaging Lot (Box and Vial): A03322003
|
30 November 2024
|
11 January 2023
|
View |
2022-01-17-0012
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03321004
|
Packaging Lot (Box & Vial): A03321004
|
30 October 2023
|
20 January 2022
|